The Global Animal Health Active Pharmaceutical Ingredients Market is estimated to be USD 16.12 Bn in 2021 and is expected to reach USD 23. 63 Bn by 2026, growing at a CAGR of 7.95%.
Market Dynamics
The global animal health active pharmaceutical ingredients market is being driven by increasing animal healthcare infrastructure and facilities, rising focus on animal well-being, an increase in the number of animal healthcare NGOs, increased pet adoption, and unmet medical needs. In addition, as the economies are growing, more governments and pharmaceutical firms are investing in animal healthcare, and the rising research and development activities and the growing focus on innovations are projected to offer lucrative growth opportunities for the growth of global animal health active pharmaceutical ingredients market.
However, the market's development is being restrained by rising costs and the Government's regulatory prohibitions on the animal pharmaceuticals industry.
Market Segmentation
The Global Animal Health Active Pharmaceutical Ingredients Market is segmented further based on Business, Indication, Synthesis, Type, End-User, and Geography.
By Business, the market is classified into captive API and merchant API. Amongst the two, the captive APIsegment is estimated to hold the highest market share during the forecast period.
By Indication, the market is classified as anti-infective, antiparasitics, and NSAIDS & anesthetics. Amongst all, the anti-infective segment is estimated to hold the highest market share during the forecast period.
By Synthesis, the market is classified as biotech and synthetic. Amongst the two, the biotech segment is estimated to hold the highest market share during the forecast period.
By Type, the market is classified as branded and generic. Amongst the two, the branded segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as pet care hospitals, retail, and specialty pharmacies. Amongst all, the pet care hospitals segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. INROADS partners with Zoetis for diversity opportunities in animal health. - 9th February 2021.
2. Olon S.p.A., a world-leading active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation.- 25th January 2019.
Company Profiles
Some of the companies covered in this report are Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co Ltd, Eli Lilly & Co, Excel Industries Ltd, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The global animal health active pharmaceutical ingredients market is being driven by increasing animal healthcare infrastructure and facilities, rising focus on animal well-being, an increase in the number of animal healthcare NGOs, increased pet adoption, and unmet medical needs. In addition, as the economies are growing, more governments and pharmaceutical firms are investing in animal healthcare, and the rising research and development activities and the growing focus on innovations are projected to offer lucrative growth opportunities for the growth of global animal health active pharmaceutical ingredients market.
However, the market's development is being restrained by rising costs and the Government's regulatory prohibitions on the animal pharmaceuticals industry.
Market Segmentation
The Global Animal Health Active Pharmaceutical Ingredients Market is segmented further based on Business, Indication, Synthesis, Type, End-User, and Geography.
By Business, the market is classified into captive API and merchant API. Amongst the two, the captive APIsegment is estimated to hold the highest market share during the forecast period.
By Indication, the market is classified as anti-infective, antiparasitics, and NSAIDS & anesthetics. Amongst all, the anti-infective segment is estimated to hold the highest market share during the forecast period.
By Synthesis, the market is classified as biotech and synthetic. Amongst the two, the biotech segment is estimated to hold the highest market share during the forecast period.
By Type, the market is classified as branded and generic. Amongst the two, the branded segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as pet care hospitals, retail, and specialty pharmacies. Amongst all, the pet care hospitals segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. INROADS partners with Zoetis for diversity opportunities in animal health. - 9th February 2021.
2. Olon S.p.A., a world-leading active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation.- 25th January 2019.
Company Profiles
Some of the companies covered in this report are Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co Ltd, Eli Lilly & Co, Excel Industries Ltd, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Animal Health Active Pharmaceutical Ingredients Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Animal Health Active Pharmaceutical Ingredients Market
What is the estimated value of the Global Animal Health Active Pharmaceutical Ingredients Market?
What is the growth rate of the Global Animal Health Active Pharmaceutical Ingredients Market?
What is the forecasted size of the Global Animal Health Active Pharmaceutical Ingredients Market?
Who are the key companies in the Global Animal Health Active Pharmaceutical Ingredients Market?
Report Attribute | Details |
---|---|
No. of Pages | 189 |
Published | May 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 16120 Million |
Forecasted Market Value ( USD
| USD 23630 Million |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |
No. of Companies Mentioned | 20 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Animal Health Active Pharmaceutical Ingredients Market, By Business
7 Global Animal Health Active Pharmaceutical Ingredients Market, By Indication
8 Global Animal Health Active Pharmaceutical Ingredients Market, By Synthesis
9 Global Animal Health Active Pharmaceutical Ingredients Market, By Type
10 Global Animal Health Active Pharmaceutical Ingredients Market, By End User
11 Global Animal Health Active Pharmaceutical Ingredients Market, By Geography
12 Competitive Landscape
13 Company Profiles
14 Appendix
Companies Mentioned
- Blanver Farmoquimica E Farmaceutica S.A
- Changzhou Yabang-Qh Pharmachem Co., Ltd
- Eli Lilly & Co
- Excel Industries Ltd
- Glenmark Pharmaceutical Ltd.
- Huvepharma
- Indukern, S.A
- Lonza Group AG
- NGL Fine Chem Ltd
- Ningxia Tairui Pharma CO. Ltd
- Ofichem BV
- Omkar Speciality Chemicals Limited
- Ourofino Saúde Animal
- P&R SpA (Olon SpA)
- Sanofi Winthrop Industrie (CEPiA)
- Sequent Scientific Ltd
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
- Shanghai Pharmtech Co. Ltd
- Zhejiang Hisun Pharmaceutical Co. Ltd
- Zoetis Inc.